Billiontoone Inc - Class A risk profile
33 Normal where most of the sector sits
Measured 21 October 2026 from BLLN's filed statements. Recomputed nightly.
33 (Normal), driven by Market expectation at 64, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 64 | Stretched | Volatile | One-year price volatility — 89.9% |
| Operating pressure | 1 | Contained | Stable | Input-cost exposure — 0.01 |
| Cash conversion | 26 | Normal | Easing | Capital spending against operating cash — 0.36x |
| Leverage and coverage | 0 | Contained | Easing | Net debt to EBITDA — -19.14x |
| Competitive position | 57 | Elevated | Stable | Operating-margin gap against peers — -2.3 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Billiontoone Inc - Class A